Intellia Therapeutics Inc. trailing returns
Intellia Therapeutics Inc.'s 10-year return is -1.2% a year (CAGR) (-11.2% cumulative). How Intellia Therapeutics Inc. (NTLA) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | +0.7% | +0.0% | +0.7% | — |
| 5 days | -12.6% | +0.0% | -12.6% | -13.2%Oct 15 |
| 1 month | -0.6% | +0.0% | -0.6% | -13.2%Oct 15 |
| YTD | +27.0% | +0.0% | +27.0% | -40.2%Jul 27 |
| 1 year | -54.2% | +0.0% | -54.2% | -71.3%Nov 2025 |
| 5 years | -38.6% | +0.0% | -38.6%-91.2% | -95.5%Apr 2025 |
| 10 years | -1.2% | +0.0% | -1.2%-11.2% | -96.4%Apr 2025 |
| Since inception (2016) | -6.1% | +0.0% | -6.1%-48.3% | -96.4%Apr 2025 |
Growth of NTLA#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years-38.6%/year · -91.2%
- 10 years-1.2%/year · -11.2%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in NTLA's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Intellia Therapeutics Inc.'s 10-year return?
- Over the last 10 years, Intellia Therapeutics Inc. (NTLA) returned about -1.2% a year annualized (-11.2% cumulative total return).
- What is Intellia Therapeutics Inc.'s return since inception?
- Since 2016, Intellia Therapeutics Inc. (NTLA) has compounded at about -6.1% a year — -48.3% in total.